Skip to content

Lens biology and pathogenesis

TL;DR — Lens transparency depends on organelle-free fibre cells packing crystallin protein at up to ~900 mg/mL in short-range order, kept soluble by α-crystallin chaperone activity and defended by a high-glutathione, low-oxygen environment (Muranov 2022, PMID 35508906; Horwitz 2003, PMID 12565801). Age-related nuclear cataract is fundamentally an oxidation event, and the proximate cause is a transport failure: a barrier to small-molecule movement between the metabolically active cortex and the quiescent nucleus appears in middle age, and once nuclear GSH falls below roughly 2 mM, protein sulfhydryl and methionine oxidation proceeds — >90% of cysteine and half of methionine residues are oxidised in advanced nuclear cataract (Truscott 2000, PMID 10971179; Truscott 2005, PMID 15862178). Cortical and posterior subcapsular cataract follow different routes, dominated by epithelial injury, osmotic stress and light exposure. Lanosterol reverses crystallin aggregation in vitro and in animal lenses and LSS mutations cause human congenital cataract (Zhao 2015, PMID 26200341), which is the strongest existing proof that aggregation is in principle reversible — but no human study has shown target engagement in vivo. The same lens epithelial cells that fail here are the ones that cause posterior capsule opacification after surgery.

Architecture of transparency

The lens is avascular, has no innervation, and is enclosed in a capsule. A single anterior epithelial monolayer supplies metabolic activity; at the equator these cells elongate into fibre cells that lose nuclei and other organelles, which removes the largest light-scattering structures. The residual cytoplasm is crystallin protein at concentrations far above those tolerated by most tissues; transparency arises from short-range spatial order among these molecules rather than from low protein content (PMID 35508906). Three conditions maintain the state:

  1. Low oxygen. Oxygen tension in the lens is unusually low; loss of that shield permits oxidation of crystallins, protein denaturation, aggregation, and formation of multilamellar bodies — the proposed common final pathway across cataractogenic exposures including age, radiation, UV and diabetes (PMID 35508906).
  2. A high-capacity antioxidant system. Glutathione is present in unusually high concentration, coupled to a redox cycle located in the epithelium and superficial cortex, and detoxifies H₂O₂ and dehydroascorbate; GSH also scavenges hydroxyl radical in lens epithelial cells independently of H₂O₂ detoxification (Giblin 2000, PMID 10803423).
  3. Chaperone buffering. αA- and αB-crystallin are small heat-shock proteins with chaperone-like function that hold partially unfolded client crystallins in a soluble state; mutations in either can cause cataract (and, for αB, myopathy) (PMID 12565801). The disordered N-terminal region encodes much of the chaperone activity toward the classic lens client γD-crystallin (Woods 2023, PMID 36719917).

Because fibre cells are never replaced, every post-translational modification accumulated in the lens nucleus is permanent. The lens grows throughout life, so the core is exposed longest, and non-enzymatic post-translational modification with accumulation of fluorescent chromophores increases susceptibility to oxidation and cross-linking — the biochemical substrate of brunescent nuclear cataract, and of presbyopia through nuclear stiffening (Michael 2011, PMID 21402586).

The barrier hypothesis for nuclear cataract

Truscott's account, now the dominant framework, has three steps:

  1. In the fourth decade a barrier to small-molecule transport develops around the lens nucleus, impeding flux between cortex and nucleus (PMID 10971179).
  2. Nuclear GSH therefore falls, and the half-lives of reactive species — UV filter degradation products, ascorbate breakdown products — rise inside the nucleus.
  3. Below a nuclear GSH threshold of roughly 2 mM, protein oxidation begins and progresses: loss of protein sulfhydryls and oxidation of methionine residues advance with cataract severity until >90% of cysteine and about half of methionine are oxidised in the most advanced cataracts (PMID 15862178).

Two implications follow that are easy to miss. First, the cortex and epithelium can remain perfectly functional while the nucleus oxidises — so "lens health" measured at the surface is not informative about the nucleus (PMID 10971179). Second, ageing and cataract are distinct: there may be no significant protein oxidation in the lens centre with advancing age past 80 in the absence of cataract, so cataract is not simply amplified ageing (PMID 15862178).

An internal microcirculation has been proposed as the lens's active delivery route for antioxidants to metabolically distinct regions — relevant because it explains why systemic antioxidant supplementation may never reach the compartment that needs it (Braakhuis 2019, PMID 31137834).

Oxidative injury: the biomarker set

Marker Role Direction in cataract Source
Glutathione (GSH) Principal lens antioxidant; depleted by enzyme loss and altered connexin expression impairing diffusion Decreased, especially centrally Lee 2024, PMID 37882550; PMID 10803423
Superoxide dismutase (SOD1) Superoxide dismutation Association with increased cataract development; gel formulations protective against PSC in models PMID 37882550
Malondialdehyde, 4-hydroxynonenal Lipid peroxidation products Increase with disease severity PMID 37882550
N-acetylcysteine GSH precursor Improves lens opacity when applied topically in models PMID 37882550

Photochemical generation of superoxide and its derivatives (singlet oxygen, hydroxyl radical, H₂O₂) damages the lens cation pump and peroxidises membrane lipids in organ culture; superoxide and H₂O₂ scavengers and vitamins C and E attenuate both effects, which is the classical experimental basis for the antioxidant hypothesis (Varma 1984, PMID 6360540). The epidemiological translation of that hypothesis has been much weaker — see non-surgical and preventive approaches.

Crystallin aggregation and its reversibility

Any disruption of intra- or inter-crystallin interactions exposes hydrophobic surfaces and drives aggregation. Lanosterol, an amphipathic sterol enriched in the lens and made by lanosterol synthase (LSS), was identified through two homozygous LSS missense mutations (W581R, G588S) in families with extensive congenital cataract; wild-type but not mutant LSS prevented intracellular aggregation, and lanosterol reduced aggregation in vitro and in animal lenses (PMID 26200341). Two independent chemical classes — 25-hydroxycholesterol and lanosterol — have now been reported to dissolve crystallin aggregates, establishing that aggregation is not necessarily an endpoint (Xu 2020, PMID 33313297). What is missing is any human demonstration that a topically applied agent reaches the lens nucleus at an active concentration and changes protein state rather than transient optical properties.

Delivery, not chemistry, is the current bottleneck. Experimental systems now target the problem directly: cell-penetrating-peptide-functionalised biomimetic nanovesicles carrying curcumin have been engineered for corneal penetration with lens-epithelial and mitochondrial dual targeting via Nrf2 activation (Zhang 2026, PMID 41323208), and cyclic-CPP-modified ceria nanoparticles opened corneal epithelial tight junctions, enriched in mitochondria and reduced ferroptosis-driven UV cataract in vivo (Jiang 2025, PMID 40336002). Both remain preclinical. Reviews of the pharmacological landscape list antioxidants, small-molecule chaperones, aldose-reductase inhibitors and aggregation inhibitors as the four active target classes, all without established clinical translation (de Diego-García 2025, PMID 40565122).

Lens epithelial cells: the cell type that matters twice

Lens epithelial cells (LECs) are the metabolically active compartment and the source of new fibre cells. They are also where several disease routes converge:

  • Oxidative defence. β-amyloid monomers are highly expressed in healthy human LEC nuclei and act as transcriptional regulators protecting against oxidative damage; ChIP-seq comparison of age-related cataract versus healthy lens epithelium identified comparable numbers of Aβ peaks (1,648 vs 1,445) but greater enrichment in healthy epithelium, with CDC25B validated as a target (Xu 2021, PMID 34478836).
  • Epithelial death opens the oxygen gate. In the unified model of cataractogenesis, cataractogenic factors damage and kill lens epithelium, gaps in the epithelial layer allow oxygen into the lens, and crystallin oxidation, denaturation and aggregation follow (PMID 35508906).
  • They cause posterior capsule opacification. Residual LECs on the anterior capsule proliferate, migrate onto the posterior capsule and undergo epithelial–mesenchymal transition, producing fibrotic and regenerative PCO (Wormstone 2021, PMID 32977000). Senescent LECs with a senescence-associated secretory phenotype drive the delayed form (Ma 2025, PMID 40660668). This is treated in full in posterior capsule opacification.

Route-specific pathogenesis

Route Mechanism Phenotype Source
Ageing/oxidation Barrier formation, GSH depletion, crystallin oxidation and cross-linking Nuclear, brunescent PMID 10971179; PMID 15862178; PMID 21402586
Ultraviolet Photochemical superoxide generation, lipid peroxidation, pump inhibition Cortical predominantly PMID 6360540; Löfgren 2017, PMID 27260484
Diabetes Polyol pathway flux through aldose reductase with sorbitol accumulation and osmotic stress; glycation; oxidative stress; altered enzyme expression compared with senile cataract Earlier onset, cortical and PSC Mishra 2023, PMID 37322647; Kiziltoprak 2019, PMID 30891150
Axial myopia Vitreous liquefaction, excess reactive oxygen species, impaired antioxidant defence, chronic intraocular inflammation, disrupted mitochondrial homeostasis and adverse epigenetic modification Nuclear and PSC, earlier onset Świerczyńska 2025, PMID 39813957
Calcium dysregulation Unregulated Ca²⁺-mediated proteolysis of lens proteins by calpains Animal and some human forms Biswas 2004, PMID 15102361
Congenital/genetic Mutations in crystallins, connexins, aquaporin, cytoskeletal proteins, developmental regulators; LSS; PIKFYVE Morphology varies by gene Pichi 2016, PMID 27043388; PMID 26200341; Mei 2022, PMID 35023829

Diabetic and age-related cataract are biochemically comparable but not identical: a narrative review identified 17 enzymes and 7 biochemical parameters altered in senile and diabetic cataract, with most parameters moving in the same direction but the diabetic lens showing an additional hyperglycaemia-specific component (PMID 37322647).

Why mechanism has not yet produced a drug

Four constraints recur across the reviews:

  1. Anatomic inaccessibility. The lens sits behind cornea, aqueous and capsule; topical agents must cross all three (PMID 41323208).
  2. Irreversibility of accumulated damage. Fibre cells are not replaced, so any agent must dissolve existing aggregates rather than prevent new ones (PMID 33313297).
  3. Compartmentation. The very barrier that causes nuclear cataract also blocks drug entry into the nucleus (PMID 10971179).
  4. No validated human pharmacodynamic marker. Candidate oxidative markers (GSH, SOD, MDA, 4-HNE) are measured in lens tissue and animal models, not non-invasively in living human eyes (PMID 37882550).

Open questions

  • Is the cortex–nucleus barrier modifiable? The barrier is the proposed proximate cause of nuclear cataract (PMID 10971179; PMID 15862178), but no intervention study — pharmacological or otherwise — has attempted to measure or shift it in human lenses.
  • Can nuclear GSH be measured non-invasively? The 2 mM threshold is the field's central quantitative claim about nuclear cataract (PMID 15862178) and yet there is no validated in-vivo human assay, so no trial can demonstrate target engagement (PMID 37882550).
  • Does lanosterol or 25-hydroxycholesterol reach the human lens? Aggregate reversal is established in vitro and in animal lenses (PMID 26200341; PMID 33313297); as of 2026-08-31 no published human pharmacokinetic study demonstrates lens-nucleus penetration at active concentration, and none was identified in the searches behind this page.
  • Is the α-crystallin chaperone reserve a tractable target? Chaperone activity maps to a disordered region of αB-crystallin (PMID 36719917) and mutations cause human cataract (PMID 12565801), but no small molecule has been shown to augment chaperone capacity in a mammalian lens in vivo.
  • Are the senescence pathways in lens epithelium shared between cataract and PCO? Senescent LECs drive delayed PCO through the senescence-associated secretory phenotype (PMID 40660668) and epithelial injury is central to cataractogenesis (PMID 35508906); whether senolytic strategies would affect both has not been tested in either direction.

References

  1. Muranov KO, Ostrovsky MA. Biochemistry of Eye Lens in the Norm and in Cataractogenesis. Biochemistry. Biokhimiia. 2022;87:106-120. PMID 35508906
  2. Horwitz J. Alpha-crystallin. Experimental eye research. 2003;76:145-53. PMID 12565801
  3. Truscott RJ. Age-related nuclear cataract: a lens transport problem. Ophthalmic research. 2000;32:185-94. PMID 10971179
  4. Truscott RJ. Age-related nuclear cataract-oxidation is the key. Experimental eye research. 2005;80:709-25. PMID 15862178
  5. Zhao L, Chen XJ, Zhu J, et al. Lanosterol reverses protein aggregation in cataracts. Nature. 2015;523:607-11. PMID 26200341
  6. Giblin FJ. Glutathione: a vital lens antioxidant. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 2000;16:121-35. PMID 10803423
  7. Woods CN, Ulmer LD, Guttman M, et al. Disordered region encodes α-crystallin chaperone activity toward lens client γD-crystallin. Proceedings of the National Academy of Sciences of the United States of America. 2023;120:e2213765120. PMID 36719917
  8. Michael R, Bron AJ. The ageing lens and cataract: a model of normal and pathological ageing. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 2011;366:1278-92. PMID 21402586
  9. Braakhuis AJ, Donaldson CI, Lim JC, et al. Nutritional Strategies to Prevent Lens Cataract: Current Status and Future Strategies. Nutrients. 2019;11. PMID 31137834
  10. Lee B, Afshari NA, Shaw PX. Oxidative stress and antioxidants in cataract development. Current opinion in ophthalmology. 2024;35:57-63. PMID 37882550
  11. Varma SD, Chand D, Sharma YR, et al. Oxidative stress on lens and cataract formation: role of light and oxygen. Current eye research. 1984;3:35-57. PMID 6360540
  12. Xu J, Fu Q, Chen X, et al. Advances in pharmacotherapy of cataracts. Annals of translational medicine. 2020;8:1552. PMID 33313297
  13. Zhang R, Li W, Wang J, et al. Cell-penetrating peptide-functionalized biomimetic nanovesicles for efficient cataract treatment via enhanced corneal penetration and lens-mitochondria dual targeting. Bioactive materials. 2026;57:305-322. PMID 41323208
  14. Jiang L, Liu J, Chen S, et al. Cyclic cell-penetrating peptide-engineered ceria nanoparticles for non-invasive alleviation of ultraviolet radiation-induced cataract. Journal of nanobiotechnology. 2025;23:337. PMID 40336002
  15. de Diego-García L, Rejas-González R, Latre IC, et al. Pharmacological Strategies for Cataract Management: From Molecular Targets to Clinical Translation. International journal of molecular sciences. 2025;26. PMID 40565122
  16. Xu J, Li D, Lu Y, et al. Aβ monomers protect lens epithelial cells against oxidative stress by upregulating CDC25B. Free radical biology & medicine. 2021;175:161-170. PMID 34478836
  17. Wormstone IM, Wormstone YM, Smith AJO, et al. Posterior capsule opacification: What's in the bag?. Progress in retinal and eye research. 2021;82:100905. PMID 32977000
  18. Ma Y, Ren Z, Chen Y, et al. Novel Insight of Posterior Capsule Opacification: The Role of Lens Epithelial Cell Senescence. Clinical & experimental ophthalmology. 2025;53:1008-1024. PMID 40660668
  19. Löfgren S. Solar ultraviolet radiation cataract. Experimental eye research. 2017;156:112-116. PMID 27260484
  20. Mishra D, Kashyap A, Srivastav T, et al. Enzymatic and biochemical properties of lens in age-related cataract versus diabetic cataract: A narrative review. Indian journal of ophthalmology. 2023;71:2379-2384. PMID 37322647
  21. Kiziltoprak H, Tekin K, Inanc M, et al. Cataract in diabetes mellitus. World journal of diabetes. 2019;10:140-153. PMID 30891150
  22. Świerczyńska M, Tronina A, Smędowski A. Understanding cataract development in axial myopia: The contribution of oxidative stress and related pathways. Redox biology. 2025;80:103495. PMID 39813957
  23. Biswas S, Harris F, Dennison S, et al. Calpains: targets of cataract prevention?. Trends in molecular medicine. 2004;10:78-84. PMID 15102361
  24. Pichi F, Lembo A, Serafino M, et al. Genetics of Congenital Cataract. Developments in ophthalmology. 2016;57:1-14. PMID 27043388
  25. Mei S, Wu Y, Wang Y, et al. Disruption of PIKFYVE causes congenital cataract in human and zebrafish. eLife. 2022;11. PMID 35023829